Frontlight ResearchEarly access
CompletedNo phase
Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery
Key facts
- Who runs it
- Cumhuriyet University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 15 Jan 2026
- Ended
- 2 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Intravenous Dexmedetomidine infusion + Standard Anesthesia
- intravenous midazolam infusion + Standard anesthesia
- Record updated
- 4 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adult patients scheduled for elective coronary artery bypass graft surgery
Who cannot take part
- Patients with renal disorders,
- Patients with hepatic disorders,
- Patients with neuropsychiatric disorders,
- Patients whom informed consent could not be obtained
- Patients who declined to participate in the study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim is to compare the incidence of postoperative delirium following coronary artery bypass grafting (CABG) between patients receiving dexmedetomidine and those receiving midazolam infusions.
The 2 groups in the trial
- DexmedetomidineExisting treatment, for comparison
Following the induction of standard general anaesthesia, dexmedetomidine will be administered as a continuous intravenous infusion at a dose of 0.3-0.7 µg/kg/h.
Treatment: Intravenous Dexmedetomidine infusion + Standard Anesthesia
- MidazolamExisting treatment, for comparison
Following the induction of standard general anaesthesia, midazolam will be administered as a continuous intravenous infusion at a dose of 0.03-0.06 mg/kg/h.
Treatment: intravenous midazolam infusion + Standard anesthesia
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Comparative Evaluation of Dexmedetomidine and Midazolam ınfusions With Respect to Postoperative Delirium in Patients Undergoing Coronary Artery Bypass Grafting
- Record updated
- 4 June 2026